Incyte (INCY) Change in Account Payables (2010 - 2026)

Incyte (INCY) reported Change in Account Payables of $23.4 million for Q1 2026, up 1186.1% on a YoY basis from $1.8 million in Q1 2025, and down 28.89% quarter-over-quarter from $33.0 million in Q4 2025.

Incyte (INCY) Change in Account Payables (2010 - 2026) Analysis & Trends

Incyte has reported Change in Account Payables for 17 years, with the latest figure at $23.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables rose 1186.1% year-over-year to $23.4 million; the trailing twelve-month figure through Mar 2026 stood at $32.2 million (up 2.57% YoY), and the FY2025 full-year result was $6.6 million, down 92.56% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $23.4 million, down from $33.0 million in the prior quarter.
  • The five-year high for Change in Account Payables was $114.4 million in Q4 2022, with the low at -$221.9 million in Q1 2023.
  • Historically, Change in Account Payables has averaged $3.3 million across 5 years, with a median of $19.0 million in 2024.
  • Annual changes were most pronounced in 2023 — Change in Account Payables sank 1034.35% — and 2026, when it soared 1186.1%.
  • Incyte's Change in Account Payables stood at $114.4 million in 2022, then plunged by 126.06% to -$29.8 million in 2023, then soared by 163.9% to $19.0 million in 2024, then soared by 73.1% to $33.0 million in 2025, then fell by 28.89% to $23.4 million in 2026.
  • The last three Change in Account Payables figures came in at $23.4 million (Q1 2026), $33.0 million (Q4 2025), and -$44.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -3.26 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 35.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -9.42 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 23.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.45 Mn
Mar 31, 2026 23.45 Mn
Dec 31, 2025 32.98 Mn
Dec 31, 2025 32.98 Mn
Sep 30, 2025 -44.17 Mn
Sep 30, 2025 -44.17 Mn
Jun 30, 2025 19.91 Mn
Jun 30, 2025 19.91 Mn
Mar 31, 2025 -2.16 Mn
Mar 31, 2025 -2.16 Mn
Dec 31, 2024 19.05 Mn
Dec 31, 2024 19.05 Mn
Sep 30, 2024 30.54 Mn
Sep 30, 2024 30.54 Mn
Jun 30, 2024 -16.06 Mn
Jun 30, 2024 -16.06 Mn
Mar 31, 2024 54.64 Mn
Mar 31, 2024 54.64 Mn
Dec 31, 2023 -29.81 Mn
Dec 31, 2023 -29.81 Mn